Nuclear matrix proteins in well and poorly differentiated human breast cancer cell lines

Journal of Cellular Biochemistry

Volumn 66, Issue 1, 1997, Pages 9-15

  Samuel, Shanti K ^a   Minish, Travis M ^a   Davie, James R ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Breast cancer; Diagnostic indicators; Estrogen receptor; Nuclear matrix proteins; Well poorly differentiated human breast cancer cells

Indexed keywords

NUCLEAR PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL DIFFERENTIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PURIFICATION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

AGED; ANTIGENS, NUCLEAR; BREAST NEOPLASMS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR CELLS, CULTURED;

EID: 0030848919     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19970701)66:1<9::AID-JCB2>3.0.CO;2-V     Document Type: Article

References (33)

1. Aamdal S, Bormer O, Jorgensen O, Host H, Eilassen G, Kaalhus O, Pihl A (1984): Estrogen receptor and long term prognosis in breast cancer. Cancer 53:2525-2529.
2. Berezney R, Basler J, Hughes BB, Kaplan SC (1979): Isolation and characterization of the nuclear matrix from Zajdela ascites hepatoma cells. Cancer Res 39:3031-3039.
3. Bidwell J, Van Wijnen A, Banerjee C, Fey E, Merriman H, Penman S, Stein J, Lian J, Stein G (1994a): Parathyroid-responsive modifications in the nuclear matrix of ROS 17/2.8 rat osteosarcoma cells. Endocrinology 134:1738-1744.
4. Bidwell JP, Fey EG, van Wijnen AJ, Penman S, Stein JL, Lian JB, Stein GS (1994b): Nuclear matrix proteins distinguish normal diploid osteoblasts from osteosarcoma cells. Cancer Res 54:28-32.
5. Chen HY, Sun J-M, Hendzel MJ, Rattner JB, Davie JR (1996): Changes in the nuclear matrix of chicken erythrocytes that accompany maturation. Biochem J 320:257-265.
6. Clarke R, Dickson RB, Brunner N (1990): The process of malignant progression in human breast cancer. Ann Oncol 1:401-407.
7. Coutts AS, Davie JR, Dotzlaw H, Murphy LC (1996): Estrogen regulation of nuclear matrix-intermediate filament proteins in human breast cancer cells. J Cell Biochem 63:174-184.
8. Donat TL, Sakr W, Lehr JE, Pienta KJ (1996): Unique nuclear matrix protein alterations in head and neck squamous cell carcinomas: Intermediate biomarker candidates. Otolaryngol Head Neck Surg 114:387-393.
9. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C (1996): Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275:913-918.
10. Fey EG, Penman S (1988): Nuclear matrix proteins reflect cell type of origin in cultured human cells. Proc Natl Acad Sci U S A 85:121-125.
11. Getzenberg RH, Pienta KJ, Huang EY, Coffey DS (1991a): Identification of nuclear matrix proteins in the cancer and normal rat prostate. Cancer Res 51:6514-6520.
12. Getzenberg RH, Pienta KJ, Huang EY, Murphy BC, Coffey DS (1991b): Modifications of the intermediate filament and nuclear matrix networks by the extracellular matrix. Biochem Biophys Res Commun 179:340-344.
13. Getzenberg RH, Konety BR, Oeler TA, Quigley MM, Hakam A, Becich MJ, Bahnson RR (1996): Bladder cancer-associated nuclear matrix proteins. Cancer Res 56:1690-1694.
14. Godolphin W, Elwood JM, Spinelli JJ (1981): Estrogen receptor quantitation and staging as complementary prognostic indicators in breast cancer: A study of 583 patients. Int J Cancer 28:677-683.
15. Keesee SK, Meneghini MD, Szaro RP, Wu Y-J (1994): Nuclear matrix proteins in human colon cancer. Proc Nat lAcad Sci U S A 91:1913-1916.
16. Khanuja PS, Lehr JE, Soule HD, Gehani SK, Noto AC, Choudhury S, Chen R, Pienta KJ (1993): Nuclear matrix proteins in normal and breast cancer cells. Cancer Res 53:3394-3398.
17. Kuller LH (1995): The etiology of breast cancer-from epidemiology to prevention. Public Health Rev 23:157-213.
18. Leonessa F, Boulay V, Wright A, Thompson EW, Brunner N, Clarke R (1992): The biology of breast tumor progression. Acquisition of hormone independence and resistance to cytotoxic drugs. Acta Oncol 31:115-123.
19. Mattern KA, Humbel BM, Muijsers AO, de Jong L, van Driel R (1996): HnRNP proteins and B23 are the major proteins of the internal nuclear matrix of HeLa S3 cells. J Cell Biochem 62:275-289.
20. McGuire WL, Clark GM, Dressler LG, Owens MA (1986): Role of steroid hormone receptors as prognostic factors in primary breast cancer. NCI Monogr 19-23.
21. Michelotti GA, Michelotti EF, Pullner A, Duncan RC, Eick D, Levens D (1996): Multiple single-stranded cis elements are associated with activated chromatin of the human c-myc gene in vivo. Mol Cell Biol 16:2656-2669.
22. Miller TE, Beausang LA, Winchell LF, Lidgard GP (1992): Detection of nuclear matrix proteins in serum from cancer patients. Cancer Res 52:422-427.
23. Pardee AB (1989): Principles of cancer biology: Biochemistry and cell biology. In Devita VT, Hellman (eds): "CANCER, Principles and Practices of Oncology." Philadelphia: J.B. Lippincott.
24. Partin AW, Getzenberg RH, CarMichael MJ, Vindivich D, Yoo J, Epstein JI, Coffey DS (1993): Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Cancer Res 53:744-746.
25. Pienta KJ, Murphy BC, Getzenberg RH, Coffey DS (1991): The effect of extracellular matrix interactions on morphologic transformation in vitro. Biochem Biophys Res Commun 179:333-339.
26. Raymond WA, LeongAS (1989a): Vimentin - a new prognostic parameter in breast carcinoma? J Pathol 158:107-114.
27. Raymond WA, LeongAS (1989b): Co-expression of cytokeratin and vimentin intermediate filament proteins in benign and neoplastic breast epithelium. J Pathol 157:299-306.
28. Replogle TS, Pienta KJ (1996): Role of the nuclear matrix in breast cancer. In Dickson R, Lippman M (eds): "Mammary Tumor Cell Cycle, Differentiation, and Metastasis." Boston/Dordrecht/London: Kluwer Academic Publishers, pp 127-140.
29. Replogle-Schwab TS, Pienta KJ, Getzenberg RH (1996): The utilization of nuclear matrix proteins for cancer diagnosis. Grit Rev Eukaryot Gene Expr 6:103-113.
30. Ruiz Cabello J, Berghmans K, Kaplan O, Lippman ME, Clarke R, Cohen JS (1995): Hormone dependence of breast cancer cells and the effects of tamoxifen and estrogen: 31P NMR studies. Breast Cancer Res Treat 33:209-217.
31. Samuel SK, Minish TM, Davie JR (1997): Altered nuclear matrix protein profiles in oncogene transformed flbroblasts exhibiting high metastatic potential. Cancer Res 57:147-151.
32. Thompson EW, Paik S, Brunner N, Sommers CL, Zugmaier G, Clarke R, Shima TB, Torri J, Donahue S, Lippman ME, Martin GR, Dickson RB (1992): Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 150:534-544.
33. Watson PH, Snell L, Parisien M (1996): The NCIC-Manitoba breast tumour bank: A resource for applied cancer research. Can Med Assoc. J 155:281-283.